...
首页> 外文期刊>EJNMMI Research >Accelerated 99mTc-sestamibi clearance associated with mitochondrial dysfunction and regional left ventricular dysfunction in reperfused myocardium in patients with acute coronary syndrome
【24h】

Accelerated 99mTc-sestamibi clearance associated with mitochondrial dysfunction and regional left ventricular dysfunction in reperfused myocardium in patients with acute coronary syndrome

机译:急性冠状动脉综合征患者再灌注心肌中 99m Tc-sestamibi清除率与线粒体功能障碍和局部左心室功能障碍相关

获取原文

摘要

Background Accelerated clearance of~(99m)technetium-sestamibi (MIBI) has been observed after reperfusion therapy in patients with acute coronary syndrome (ACS), but the mechanisms have not been fully investigated. MIBI retention may depend on mitochondrial function. The clearance rate of~(11)carbon-acetate reflects such mitochondrial functions as oxidative metabolism. The purpose of this study was to examine the mechanisms of accelerated MIBI clearance in ACS. We therefore compared it to oxidative metabolism estimated using~(11)C-acetate positron emission tomography (PET). Methods Eighteen patients [mean age 69.2?±?8.7?years, 10 males (56?%)] with reperfused ACS underwent MIBI single-photon emission computed tomography (SPECT), echocardiography, and~(11)C-acetate PET within 3?weeks of the onset of ACS. MIBI images were obtained 30?min and 3?h after MIBI administration. Regional left ventricular (LV) function was evaluated by echocardiography. The measurement of oxidative metabolism was obtained through the mono-exponential fitting of the~(11)C-acetate time-activity curve ( k _(mono)). Results Among 95 segments of reperfused myocardium, MIBI SPECT showed 64 normal segments (group N), 14 segments with accelerated MIBI clearance (group AC), and 17 segments with fixed defect (group F). Group AC showed lower k _(mono)than group N (0.041?±?0.009 vs 0.049?±?0.010, p ?=?0.02). Group F showed lower k _(mono)than group N (0.039?±?0.012 vs 0.049?±?0.010, p ?=?0.01). However, k _(mono)was similar in group AC and group F ( p ?=?0.99). Conclusions Segments with accelerated MIBI clearance showed reduced oxidative metabolism in ACS. Loss of MIBI retention may be associated with mitochondrial dysfunction.
机译:背景技术在急性冠脉综合征(ACS)患者中,在进行再灌注治疗后,观察到〜(99m)s-甾烷(MIBI)的清除率加快,但是其机理尚未得到充分研究。 MIBI保留可能取决于线粒体功能。 〜(11)乙酸碳的清除率反映了线粒体功能,如氧化代谢。这项研究的目的是检查ACS中MIBI清除加速的机制。因此,我们将其与使用〜(11)C-乙酸正电子发射断层扫描(PET)估计的氧化代谢进行了比较。方法对18例[平均年龄69.2±±8.7岁的患者,10例男性(56%)]进行了MIBI单光子发射断层扫描(SPECT),超声心动图,〜(11)C-醋酸PET ACS发作几周。 MIBI给药30分钟和3小时后获得MIBI图像。通过超声心动图评估区域左心室(LV)功能。通过〜(11)C-乙酸盐时间-活性曲线的单指数拟合(k _(mono))获得氧化代谢的测量值。结果在95个再灌注心肌节段中,MIBI SPECT显示64个正常节段(N组),14个MIBI清除加速段(AC组)和17个固定缺损段(F组)。 AC组的k _(mono)比N组低(0.041±±0.009 vs 0.049±±0.010,p≥0.02。 F组的k _(mono)比N组低(0.039±±0.012 vs 0.049±±0.010,p≥0.01)。但是,在AC组和F组中,k _(mono)相似(p≤0.99)。结论加速MIBI清除的节段显示ACS的氧化代谢降低。 MIBI保留的丧失可能与线粒体功能障碍有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号